|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 6600 SW 92ND AVENUE, SUITE 300 |
Address2 | |
City | PORTLAND |
State | OR |
Zip Code | 97223 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 314658-12
|
||||||||
|
6. House ID# 393810000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Alyssa L. Brown, Advocacy Outreach Manager |
Date | 10/20/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007
S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007
H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007
Section 101. EXPANSION OF BIOMEDICAL RESEARCH
Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis.
Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research.
Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY
Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry.
Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT
Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities.
Requires a report to Congress not later than 180 days after the convening of summit.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sheila |
Rittenberg |
|
|
|
Alyssa |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Access to care for people with psoriasis and psoriatic arthritis
H.R. 1188 and S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007
H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007
Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE
Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following:
(1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis;
(2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis;
(3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sheila |
Rittenberg |
|
|
|
Alyssa |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 2638, Making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2008, and for other purposes.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sheila |
Rittenberg |
|
|
|
Alyssa |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R. 2833 and S. 2236, Preexisting Condition Exclusion Patient Protection Act
H.R. 2842 and S. 3115, Children's Health Protection Act
H.R. 2833 and S. 2236, Preexisting Condition Exclusion Patient Protection Act
A bill to amend title I of the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to prohibit preexisting condition exclusions for children in group health plans and health insurance coverage in the group and individual markets.
H.R. 2842 and S. 3115, Children's Health Protection Act
To amend title I of the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to prohibit preexisting condition exclusions for children in group health plans and health insurance coverage in the group and individual markets.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sheila |
Rittenberg |
|
|
|
Alyssa |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
H.R. 3195 and S. 3406, ADA Amendments Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sheila |
Rittenberg |
|
|
|
Alyssa |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |